TL 383 TL 383 (Terazosin 1 mg)
Pill imprint TL 383 TL 383 has been identified as Terazosin hydrochloride 1 mg.
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 1 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- TL 383 TL 383
- Strength:
- 1 mg
- Color:
- Gray
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Cadista
- National Drug Code (NDC):
- 59746-0383
- Inactive Ingredients:
- ferrosoferric oxide
gelatin
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
titanium dioxide
corn starch
silicon dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 67544-0581 | Prepak Systems Inc (repackager) |
Note: Inactive ingredients may vary.
More about terazosin
Consumer resources
- Other brands: Hytrin
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
